Marian L. Birkeland

NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology

Phillip G. Febbo, Marc Ladanyi, Kenneth Aldape et al. · Journal of the National Comprehensive Cancer Network · 2011 · 253 citations · Full text

Nccn Task Force, Cancer Management, Pathology +19

Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation.

Marian L. Birkeland, Pauline Johnson, Ian S. Trowbridge et al. · Proceedings of the National Academy of Sciences · 1989 · 180 citations · Full text

Adaptive Immune System, Immunology, Immune Regulation +14

Robust B Cell Immunity but Impaired T Cell Proliferation in the Absence of CD134 (OX40)

Susanne Pippig, Claudia Peña-Rossi, James P. Long et al. · The Journal of Immunology · 1999 · 162 citations

T Cell Reactivity, Lymphocyte Development, Adaptive Immune System +17

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand

Aymen Al‐Shamkhani, Marian L. Birkeland, Michael J. Puklavec et al. · European Journal of Immunology · 1996 · 135 citations

Evolutionary relationships of Aurora kinases: Implications for model organism studies and the development of anti-cancer drugs

James R. Brown, Kristin K. Koretke, Marian L. Birkeland et al. · BMC Evolutionary Biology · 2004 · 118 citations · Full text